The DOI matches its Crossref record; 74 of the 77 references it cites were found in a registry or an index.
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Open accessAbstract
The CRISPR-associated endonuclease Cas9 can be targeted to specific genomic loci by single guide RNAs (sgRNAs). Here, we report the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 Å resolution. The structure revealed a bilobed architecture composed of target recognition and nuclease lobes, accommodating the sgRNA:DNA heteroduplex in a positively charged groove at their interface. Whereas the recognition lobe is essential for binding sgRNA and DNA, the nuclease lobe contains the HNH and RuvC nuclease domains, which are properly positioned for cleavage of the complementary and noncomplementary strands of the target DNA, respectively. The nuclease lobe also contains a carboxyl-terminal domain responsible for the interaction with the protospacer adjacent motif (PAM). This high-resolution structure and accompanying functional analyses have revealed the molecular mechanism of RNA-guided DNA targeting by Cas9, thus paving the way for the rational design of new, versatile genome-editing technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Upon binding of Streptococcus pyogenes Cas9 (SpCas9) to the target site, a stable strand separation is maintained through two kinds of interactions: the binding of gRNA to the target strand, and a positively-charged groove resulting from the unspecific interaction of both HNH and RuvC domains with the negatively-charged non-target strand [36].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [36]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“tracrRNA is complementary to the repeat sequence and contains 3 stem-loop hairpin structures [35,36].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“The structure that came out of the laboratory of Jennifer Doudna was of an apo-protein (PDBe ID 4cmp, PDBe DOI: 10.2210/pdb4cmp/pdb), while the research group of Osamu Nureki (University of Tokyo, Japan) succeeded in crystallising the protein in a complex with a “guide”-RNA and “target”-DNA (PDBe ID 4oo8, PDBe DOI: 10.2210/pdb4oo8/pdb).”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“The key structures of the nuclease lobe of SpCas9 are 2 domains: HNH and RuvC, each of them cleaves one of the target DNA strands.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, SpCas9-NG shows reduced editing efficiency on 5′-NGC-3′ PAM targets and tends to increase off-target activity (Nishimasu et al., 2014).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Nishimasu et al., 2014
Experimental — accuracy not yet measured
In the citing paper
“Crystal structures revealed that the Cas9 protein is spatially divided into 2 lobes: a target recognition lobe and a nuclease lobe, with the guide RNA and target DNA occupying the positively charged groove at their interface.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
In the citing paper
“Attempts to obtain detailed information about the structure of this protein resulted in the first two crystallographic studies being published almost simultaneously: in February 2014 two crystal structures of Cas9 appeared in the database PDBe (“Protein Data Bank in Europe”), and the accompanying articles were published in the journals Nature and Cell [39, 40].”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
In the citing paper
“These, as well as many subsequent studies, used the Cas9 protein from S. pyogenes, SpCas9, which consists of 1368 amino acids and is a multidomain and multifunctional endonuclease.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2007) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 88,113
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citation
Flagged first, then by citations
3 of the 77 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Cowtan, 1994, ‘dm’: An automated procedure for phase improvement by density modification, Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography, 31, 34
Cited by
Sorted by citations
Items 701–800 of 1,002
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics
Berber, B., Aydın, C., Kocabaş, F., Güney-Esken, G., Yılancıoğlu, K., Alpaslan, M. K., Çalıseki, M., Yüce, M., Demir, S., & Taştan, C. (2020) · Gene Therapy · doi:10.1038/s41434-020-00209-7 · Cited by 52
Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules
Shams, A., Higgins, S. A., Fellmann, C., Laughlin, T. G., Oakes, B. L., Lew, R., Kim, S., Lukarska, M., Arnold, M. L., Staahl, B. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25992-8 · Cited by 50
Sufyan, M., Daraz, U., Hyder, S., Zulfiqar, U., Iqbal, R., Eldin, S. M., Rafiq, F., Mahmood, N., Shahzad, K., Uzair, M., et al. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01036-w · Cited by 55
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Pinjala, P., Tryphena, K. P., Prasad, R., Khatri, D. K., Sun, W., Singh, S. B., Gugulothu, D. B., Srivastava, S., & Vora, L. K. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00381-y · Cited by 57
CRISPR-mediated control of the bacterial initiation of replication
Wiktor, J., Lesterlin, C., Sherratt, D. J., & Dekker, C. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw214 · Cited by 50
Chimeric Guides Probe and Enhance Cas9 Biochemical Activity
Kartje, Z. J., Barkau, C. L., Rohilla, K. J., Ageely, E. A., & Gagnon, K. T. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00107 · Cited by 48
Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9
Iwasaki, R. S., Akdogan‐Ozdilek, B., Garst, A. D., Choudhury, A., & Batey, R. (2020) · Nature Communications · doi:10.1038/s41467-020-15226-8 · Cited by 50
CRISPR: History and perspectives to the future
Kozovská, Z., Rajcaniova, S., Munteanu, P., Dzacovska, S., & Demková, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111917 · Cited by 60
Mullally, G., van Aelst, K., Naqvi, M. M., Diffin, F., Karvelis, T., Gasiunas, G., Šikšnys, V., & Szczelkun, M. (2020) · bioRxiv · doi:10.1093/nar/gkaa477 · Cited by 44
CRISPR/Cas technology as a promising weapon to combat viral infections
Escalona‐Noguero, C., López‐Valls, M., & Sot, B. (2021) · BioEssays · doi:10.1002/bies.202000315 · Cited by 49
Guyon, A., Rousseau, J., Bégin, F.-G., Bertin, T., Lamothe, G., & Tremblay, J. P. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.032 · Cited by 55
Recent advances of Cas12a applications in bacteria
Meliawati, M., Schilling, C., & Schmid, J. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11243-9 · Cited by 51
Compendium of Plant-Specific CRISPR Vectors and Their Technical Advantages
Alok, A., Chauhan, H., Upadhyay, S. K., Pandey, A. K., Kumar, J., & Singh, K. (2021) · Life · doi:10.3390/life11101021 · Cited by 51
Son, H., Park, J.-I., Hwang, I., Jung, Y., Bae, S., & Lee, S.-H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113747118 · Cited by 52
Structure of the IscB–ωRNA ribonucleoprotein complex, the likely ancestor of CRISPR-Cas9
Kato, K., Okazaki, S., Kannan, S., Altae-Tran, H., Demircioglu, F. E., Isayama, Y., Ishikawa, J., Fukuda, M., Macrae, R. K., Nishizawa, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34378-3 · Cited by 51
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense
Li, Y., Shen, Z., Zhang, M., Yang, X., Cleary, S. P., Xie, J., Marathe, I. A., Kostelic, M. M., Greenwald, J., Rish, A. D., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01172-8 · Cited by 49
The Power of CRISPR-Cas9-Induced Genome Editing to Speed Up Plant Breeding
Cao, H. X., Wang, W., Hiền, L. T. T., & Vu, G. T. H. (2016) · International Journal of Genomics · doi:10.1155/2016/5078796 · Cited by 52
Real‐time observation of flexible domain movements in CRISPR–Cas9
Osuka, S., Isomura, K., Kajimoto, S., Komori, T., Nishimasu, H., Shima, T., Nureki, O., & Uemura, S. (2018) · The EMBO Journal · doi:10.15252/embj.201796941 · Cited by 49
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
Baliou, S., Adamaki, M., Kyriakopoulos, A. M., Spandidos, D. A., Panayiotidis, M. I., Christodoulou, I., & Zoumpourlis, V. C. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4434 · Cited by 55
Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair
Sansbury, B. M., Hewes, A. M., & Kmiec, E. B. (2019) · Communications Biology · doi:10.1038/s42003-019-0705-y · Cited by 49
Kulcsár, P. I., Tálas, A., Tóth, E., Nyeste, A., Ligeti, Z., Welker, Z., & Welker, E. (2020) · Nature Communications · doi:10.1038/s41467-020-15021-5 · Cited by 45
Inhibition of CRISPR-Cas12a DNA targeting by nucleosomes and chromatin
Strohkendl, I., Saifuddin, F. A., Gibson, B. A., Rosen, M. K., Russell, R., & Finkelstein, I. J. (2021) · Science Advances · doi:10.1126/sciadv.abd6030 · Cited by 48
Guide RNAs containing universal bases enable Cas9/Cas12a recognition of polymorphic sequences
Krysler, A. R., Cromwell, C. R., Tu, T., Jovel, J., & Hubbard, B. P. (2022) · Nature Communications · doi:10.1038/s41467-022-29202-x · Cited by 49
Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems
Wu, H., Liu, Q., Shi, H., Xie, J., Zhang, Q., Ouyang, Z., Li, N., Yang, Y., Liu, Z., Zhao, Y., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2810-3 · Cited by 49
Structural basis for the promiscuous PAM recognition by Corynebacterium diphtheriae Cas9
Hirano, S., Abudayyeh, O. O., Gootenberg, J. S., Horii, T., Ishitani, R., Hatada, I., Zhang, F., Nishimasu, H., & Nureki, O. (2019) · Nature Communications · doi:10.1038/s41467-019-09741-6 · Cited by 47
Historic Overview of Genetic Engineering Technologies for Human Gene Therapy
Tamura, R., & Toda, M. (2020) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2020-0049 · Cited by 52
Replisome bypass of a protein-based R-loop block by Pif1
Schauer, G. D., Spenkelink, L. M., Lewis, J. S., Yurieva, O., Mueller, S. H., van Oijen, A. M., & O’Donnell, M. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020189117 · Cited by 48
Wang, X., Dong, K., Kong, D., Zhou, Y., Yin, J., Cai, F., Wang, M., & Ye, H. (2021) · Science Advances · doi:10.1126/sciadv.abh2358 · Cited by 47
Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
Bhattacharya, S., & Satpati, P. (2022) · ACS Omega · doi:10.1021/acsomega.2c05583 · Cited by 51
Genome editing in the treatment of ocular diseases
Choi, E. H., Suh, S., Sears, A. E., Hołubowicz, R., KEDHAR, S. R., Browne, A., & Palczewski, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01057-2 · Cited by 51
CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations
Lee, H., Rho, W., Kim, Y.-H., Chang, H., & Jun, B. (2025) · Molecules · doi:10.3390/molecules30030542 · Cited by 59
Structural basis of stringent PAM recognition by CRISPR-C2c1 in complex with sgRNA
Wu, D., Guan, X., Zhu, Y., Ren, K., & Huang, Z. (2017) · Cell Research · doi:10.1038/cr.2017.46 · Cited by 47
CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
Lone, B. A., Karna, S. K. L., Ahmad, F., Shahi, N., & Pokharel, Y. R. (2018) · Genetics Research International · doi:10.1155/2018/3797214 · Cited by 48
The CRISPR-cas System Promotes Antimicrobial Resistance in Campylobacter Jejuni
Shabbir, M. A. B., Wu, Q., Shabbir, M. Z., Sajid, A., Ahmed, S., Sattar, A., Tang, Y., Li, J., Maan, M. K., Hao, H., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0234 · Cited by 48
Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage
Zuo, Z., & Liu, J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.013 · Cited by 51
Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3
Carabias, A., Fuglsang, A., Temperini, P., Pape, T., Sofos, N., Stella, S., Erlendsson, S., & Montoya, G. (2021) · Nature Communications · doi:10.1038/s41467-021-24707-3 · Cited by 44
The “guiding” principles of noncoding RNA function
Deogharia, M., & Gurha, P. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1704 · Cited by 47
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
Huang, H., Huang, G., Tan, Z., Hu, Y., Shan, L., Zhou, J., Zhang, X., Ma, S., Lv, W., Huang, T., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01296-1 · Cited by 46
Babu, K., Kathiresan, V., Kumari, P., Newsom, S. N., Parameshwaran, H. P., Chen, X., Liu, J., Qin, P. Z., & Rajan, R. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00354 · Cited by 46
The Central Dogma revisited: Insights from protein synthesis, CRISPR, and beyond
Ille, A. M., Lamont, H., & Mathews, M. B. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1718 · Cited by 50
Efficient precise integration of large DNA sequences with 3′-overhang dsDNA donors using CRISPR/Cas9
Han, W., Li, Z., Guo, Y., He, K., Li, W., Xu, C., Ge, L., He, M., Yin, X., Zhou, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221127120 · Cited by 45
CRISPR-Cas target recognition for sensing viral and cancer biomarkers
Rahimi, S., Balusamy, S. R., Perumalsamy, H., Ståhlberg, A., & Mijakovic̀, I. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae736 · Cited by 49
Schmieder, V., Bydlinski, N., Strasser, R., Baumann, M., Kildegaard, H. F., Jadhav, V., & Borth, N. (2017) · Biotechnology Journal · doi:10.1002/biot.201700211 · Cited by 46
Comparative genomics and evolution of trans-activating RNAs in Class 2 CRISPR-Cas systems
Faure, G., Shmakov, S., Makarova, K. S., Wolf, Y. I., Crawley, A. B., Barrangou, R., & Koonin, E. V. (2018) · RNA Biology · doi:10.1080/15476286.2018.1493331 · Cited by 47
Understanding the mechanistic basis of non-coding RNA through molecular dynamics simulations
Palermo, G., Casalino, L., Magistrato, A., & McCammon, J. A. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.03.004 · Cited by 47
Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance
Babu, K., Amrani, N., Jiang, W., Yogesha, S. D., Nguyen, R., Qin, P. Z., & Rajan, R. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01241 · Cited by 47
New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes
Kawall, K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00525 · Cited by 50
Optimizing a CRISPR-Cpf1-based genome engineering system for Corynebacterium glutamicum
Zhang, J., Yang, F., Yang, Y., Jiang, Y., & Huo, Y. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1109-x · Cited by 45
Tariq, A., Mushtaq, M., Yaqoob, H., Bhat, B. A., Zargar, S. M., Raza, A., Ali, S., Charagh, S., Mubarik, M. S., Zaman, Q. U., et al. (2023) · GM Crops & Food · doi:10.1080/21645698.2023.2219111 · Cited by 45
Liu, X., Chen, Y., Zhang, Y., Liu, Y., Liu, N., Botten, G. A., Cao, H., Orkin, S. H., Zhang, M. Q., & Xu, J. (2020) · Genome biology · doi:10.1186/s13059-020-01973-w · Cited by 44
van Hees, M., Slott, S., Hansen, A. H., Kim, H. S., Ji, H. P., & Astakhova, K. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.003 · Cited by 47
CRISPR based therapeutics: a new paradigm in cancer precision medicine
Das, S., Bano, S., Kapse, P., & Kundu, G. C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01552-6 · Cited by 47
Recent advancements in CRISPR/Cas technology for accelerated crop improvement
Das, D., Singha, D. L., Paswan, R. R., Chowdhury, N., Sharma, M., Reddy, P. S., & Chikkaputtaiah, C. (2022) · Planta · doi:10.1007/s00425-022-03894-3 · Cited by 50
CRISPR-Cas systems mediated biosensing and applications in food safety detection
Liu, J., Wu, D., Chen, J., Jia, S., Chen, J., Wu, Y., & Li, G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2128300 · Cited by 45
G-quadruplex-based CRISPR photoswitch for spatiotemporal control of genomic modulation
Deng, H., Xu, H., Wang, Y., Jia, R., Ma, X., Feng, Y., & Chen, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad178 · Cited by 45
Next-generation CRISPR-based diagnostic tools for human diseases
Wang, T., Wang, Z., Bai, L., Zhang, X., Feng, J., Qian, C., Wang, Y., & Wang, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117328 · Cited by 46
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Deneault, É. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050255 · Cited by 54
Hu, Z., Ling, S., Duan, J., Yu, Z., Che, Y., Wang, S., Zhang, S., Zhang, X., & Li, Z. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf017 · Cited by 46
Performance of the Cas9 Nickase System in Drosophila melanogaster
Ren, X., Yang, Z., Mao, D., Chang, Z., Qiao, H.-H., Wang, X., Sun, J., Hu, Q., Cui, Y., Liu, L.-P., et al. (2014) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.114.013821 · Cited by 40
Genome engineering for breaking barriers in lignocellulosic bioethanol production
Ulaganathan, K., Goud, S., Reddy, M., & Ulaganathan, K. (2017) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2017.01.028 · Cited by 45
Conformational regulation of CRISPR-associated nucleases
Jackson, R. N., van Erp, P. B. G., Sternberg, S. H., & Wiedenheft, B. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.010 · Cited by 48
Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech
Saha, S. K., Saikot, F. K., Rahman, M. S., Jamal, M. A. H. M., Rahman, S. M. K., Islam, S. M. R., & Kim, K. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.11.016 · Cited by 48
Okafor, I. C., Singh, D., Wang, Y., Jung, M., Wang, H., Mallon, J. P., Bailey, S., Lee, J. K., & Ha, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1058 · Cited by 45
NMR and computational methods for molecular resolution of allosteric pathways in enzyme complexes
East, K. W., Skeens, E., Cui, J. Y., Belato, H. B., Mitchell, B. P., Hsu, R. V., Batista, V. S., Palermo, G., & Lisi, G. P. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00609-z · Cited by 45
Qi, T., Wu, F., Xie, Y., Gao, S., Li, M., Pu, J., Li, D., Lan, F., & Wang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590581 · Cited by 45
Matsumoto, D., Tamamura, H., & Nomura, W. (2020) · Communications Biology · doi:10.1038/s42003-020-01340-2 · Cited by 46
Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1
Zhang, B., Luo, D., Li, Y., Perčulija, V., Chen, J., Lin, J., Ye, Y., & Ouyang, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23876-5 · Cited by 44
Allemailem, K. S. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s453566 · Cited by 49
Sun, K. W., Pu, L., Chen, C., Chen, M., Li, K., Li, X., Li, H., & Geng, J. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae176 · Cited by 52
Zhang, R., He, Z., Shi, Y., Sun, X., Chen, X., Wang, G., Zhang, Y., Gao, P., Wu, Y. X., Lu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.056 · Cited by 46
PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Acharya, S., Ansari, A. H., Das, P. K., Hirano, S., Aich, M., Rauthan, R., Mahato, S., Maddileti, S., Sarkar, S., Kumar, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49233-w · Cited by 47
Tuning CRISPR-Cas9 Gene Drives in Saccharomyces cerevisiae
Roggenkamp, E., Giersch, R. M., Schrock, M. N., Turnquist, E., Halloran, M., & Finnigan, G. C. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300557 · Cited by 45
Advances in genome editing for genetic hearing loss
Ding, N., Lee, S., Lieber-Kotz, M., Yang, J., & Gao, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.001 · Cited by 43
Split versions of Cleave and Rescue selfish genetic elements for measured self limiting gene drive
Oberhofer, G., Ivy, T., & Hay, B. A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009385 · Cited by 44
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Cui, Z., Tian, R., Huang, Z., Jin, Z., Li, L., Liu, J., Huang, Z., Xie, H., Liu, D., Mo, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29089-8 · Cited by 46
Richter, F. M., Fonfara, I., Gelfert, R., Nack, J., Charpentier, E., & Möglich, A. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.025 · Cited by 44
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Li, X., Wang, C., Peng, T., Chai, Z., Ni, D., Liu, Y., Zhang, J., Chen, T., & Lu, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.11.010 · Cited by 41
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 46
Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficacies
Yin, S., Zhang, M., Liu, Y., Sun, X., Guan, Y., Chen, X., Yang, L., Huo, Y., Yang, J., Zhang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.014 · Cited by 47
Byun, G., Yang, J., & Seo, S. W. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad234 · Cited by 44
Genome editing in rice using CRISPR /Cas12i3
Lv, P., Su, F., Chen, F., Yan, C., Xia, D., Sun, H., Li, S., Duan, Z., Ma, C., Zhang, H., et al. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14192 · Cited by 43
Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex
Zhu, X. Q., & Ye, K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1355 · Cited by 43
Genome Editing of Monogenic Neuromuscular Diseases
Long, C., Amoasii, L., Bassel‐Duby, R., & Olson, E. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3388 · Cited by 46
Development of versatile non-homologous end joining-based knock-in module for genome editing
Sawatsubashi, S., Joko, Y., Fukumoto, S., Matsumoto, T., & Sugano, S. S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18911-9 · Cited by 43
Analysis of CRISPR-Cas System in Streptococcus thermophilus and Its Application
Hao, M., Cui, Y., & Qu, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00257 · Cited by 43
Li, B., Yan, J., Zhang, Y., Li, W., Zeng, C., Zhao, W., Hou, X., Zhang, C., & Dong, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.038 · Cited by 43
CRISPR–Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference
Zhao, Y., & Boeke, J. D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa329 · Cited by 43
Using Gene Editing Approaches to Fine-Tune the Immune System
Pavlovic, K., Tristán‐Manzano, M., Maldonado‐Pérez, N., Cortijo-Gutierréz, M., Sánchez-Hernández, S., Justicia-Lirio, P., Carmona-Luque, M. D., Herrera, C., Martín, F., & Benabdellah, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570672 · Cited by 49
Structure of the type V-C CRISPR-Cas effector enzyme
Kurihara, N., Nakagawa, R., Hirano, H., Okazaki, S., Tomita, A., Kobayashi, K., Kusakizako, T., Nishizawa, T., Yamashita, K., Scott, D. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.006 · Cited by 42
Kulcsár, P. I., Tálas, A., Ligeti, Z., Krausz, S. L., & Welker, E. (2022) · Nature Communications · doi:10.1038/s41467-022-34527-8 · Cited by 46
Pattharaprachayakul, N., Lee, M., Incharoensakdi, A., & Woo, H. M. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109619 · Cited by 43
CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
Zegeye, W. A., Tsegaw, M., Zhang, Y., & Cao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084454 · Cited by 49
CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
Ding, S., Liu, J., Han, X., & Tang, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216325 · Cited by 51
Personalised genome editing – The future for corneal dystrophies
Moore, T., Christie, K. A., Marshall, J., & Nesbit, M. A. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.01.004 · Cited by 44
Wu, Y. C., Xu, W., Wang, F., Zhao, S., Feng, F., Song, J., Zhang, C., & Yang, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00379 · Cited by 45
CRISPR Genome Editing Systems in the Genus Clostridium : a Timely Advancement
McAllister, K. N., & Sorg, J. A. (2019) · Journal of Bacteriology · doi:10.1128/jb.00219-19 · Cited by 49
Rational design of a compact CRISPR-Cas9 activator for AAV-mediated delivery
Vora, S., Cheng, J., Xiao, R., VanDusen, N. J., Quintino, L., Pu, W. T., Vandenberghe, L. H., Chavez, A., & Church, G. (2018) · doi:10.1101/298620 · Cited by 42
Kim, D. G., Gu, B., Cha, Y., Ha, J., Lee, Y., Kim, G., Cho, B., & Oh, M. (2025) · Nature Communications · doi:10.1038/s41467-025-56278-y · Cited by 42
Metadata
- Authors
- Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O.
- Affiliations
- Japan Science and Technology Agency (JP)
- Broad Institute (US)
- RIKEN (JP)
- The University of Tokyo (JP)
- Corresponding author
- Zhang, Feng
- Nureki, Osamu
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 156
- Issue
- 5
- Pages
- 935-949
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4139937
- OpenAlex
- W2107959600
- Cited by
- 2,306
- References
- 77
- Citations by year
- 2026: 130 · 2025: 193 · 2024: 221 · 2023: 177 · 2022: 229 · 2021: 218 · 2020: 215 · 2019: 212 · 2018: 191 · 2017: 193 · 2016: 149 · 2015: 93 · 2014: 80
- FWCI
- 70.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- PRESTO from the Japan Science and Technology (JST) Agency
- Drug Discovery and Informatics
- Japan Society for the Promotion of Science (JSPS)
- Core Research for Evolutional Science and Technology (CREST)
- Japan Science and Technology Agency (JST)
- NIH (5DP1-MH100706)
- Keck
- McKnight
- Poitras
- Merkin
- Vallee
- Damon Runyon
- Searle Scholars
- Klingenstein
- Simons Foundations
- Bob Metcalfe
- Jane Pauley
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- CRISPR/Cas12a, guide RNA, target DNA, RNA-guided DNA cleavage, protospacer adjacent motif, genome editing, crystal structure
- MeSH terms
- Amino Acid Sequence, Bacteria, DNA, Bacterial, Endonucleases, Models, Molecular, Molecular Sequence Data, RNA, Bacterial, Streptococcus pyogenes, Sequence Alignment, Protein Structure, Tertiary, Crystallography, X-Ray, RNA, Small Untranslated, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
